Howard Horn, CFO at Vir Biotechnology, Inc. (VIR), sold 20,000 shares at $34.53 ($702K) on 2020-06-01, disclosed to the SEC on 2020-06-02.
Open-market sale of $702k VIR by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.53 | 3,286 | $113K | 16.2% |
| 2 | $34.53 | 3,286 | $113K | 16.2% |
| 3 | $35.38 | 6,714 | $238K | 33.8% |
| 4 | $35.38 | 6,714 | $238K | 33.8% |
| Total | $35.10 avg | 20,000 | $702K | 100% |
| Filing → |
| RARE | SELL | 2026-06-01 | $111K | — | Filing → |
| RARE | SELL | 2026-05-04 | $117K | — | Filing → |
| RARE | SELL | 2026-04-02 | $98K | — | Filing → |